These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 30684710

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke.
    Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W.
    Stroke; 1998 Aug; 29(8):1550-5. PubMed ID: 9707191
    [Abstract] [Full Text] [Related]

  • 5. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study.
    Kerwin AJ, Schinco MA, Tepas JJ, Renfro WH, Vitarbo EA, Muehlberger M.
    J Trauma; 2009 Aug; 67(2):277-82. PubMed ID: 19667879
    [Abstract] [Full Text] [Related]

  • 6. Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury.
    Mangat HS, Chiu YL, Gerber LM, Alimi M, Ghajar J, Härtl R.
    J Neurosurg; 2015 Jan; 122(1):202-10. PubMed ID: 25380107
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury.
    Chen H, Song Z, Dennis JA.
    Cochrane Database Syst Rev; 2019 Dec 30; 12(12):CD010904. PubMed ID: 31886900
    [Abstract] [Full Text] [Related]

  • 9. Comparison of equiosmolar dose of hyperosmolar agents in reducing intracranial pressure-a randomized control study in pediatric traumatic brain injury.
    Kumar SA, Devi BI, Reddy M, Shukla D.
    Childs Nerv Syst; 2019 Jun 30; 35(6):999-1005. PubMed ID: 30879126
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury.
    Chen H, Song Z, Dennis JA.
    Cochrane Database Syst Rev; 2020 Jan 17; 1(1):CD010904. PubMed ID: 31978260
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of hypertonic saline infusion in management of traumatic brain injury: an updated systematic review and meta-analysis of randomized controlled trials.
    Cai L, He W.
    Brain Inj; 2024 Oct 14; 38(12):977-984. PubMed ID: 38853675
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.